Neurodegenerative diseases such as Parkinson’s and Alzheimer’s involve the progressive loss of nerve cells, leading to movement problems, memory decline, and cognitive challenges. Because current treatments often only ease symptoms, researchers are exploring whether phytocannabinoids—naturally occurring compounds from the Cannabis sativa plant—might influence the biological processes behind these disorders. This review article summarizes recent preclinical […]
Category: CBG
Cannabigerol (CBG) and Heart Health: What Early Research Suggests (pub. March 2025)
Cardiovascular disease remains a leading cause of illness worldwide, and researchers are exploring new ways to support heart and blood vessel function. This mini‑review article looks at the therapeutic potential of cannabigerol (CBG)—a non‑psychoactive cannabinoid from the cannabis plant—with a particular focus on its possible effects on the cardiovascular system. The authors summarize laboratory and […]
Cannabigerol (CBG): A Broad Look at Its Molecular Actions and Potential Benefits (pub. Nov 2024)
Researchers are increasingly interested in cannabigerol (CBG), a non‑psychoactive cannabinoid found in the cannabis plant, because it interacts with many biological systems in the body that influence health and wellness. This comprehensive review summarizes what scientists currently know about CBG’s molecular mechanisms—how it works at the cellular level—and its therapeutic potential across a range of […]